MIRA Pharmaceuticals reports positive 7-day toxicology results for MIRA-55
MIRA Pharmaceuticals said 7-day dose-range toxicology and toxicokinetic results for MIRA-55 support dose selection and a targeted Q1 2027 IND submission.
MIRA Pharmaceuticals announced positive 7-day dose-range toxicology and toxicokinetic results for MIRA-55, informing dose selection and supporting a targeted Q1 2027 IND submission.Key Highlights:Original SEC Filing: MIRA PHARMACEUTICALS, INC. [ MIRA ] - 8-K - Sep.
01, 2026This is an AI-powered sum…